Bain Capital Specialty Finance Stock Forecast, Price & News

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BCSF stock has decreased by 37.5% and is now trading at $10.53.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bain Capital Specialty Finance.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance Inc (NYSE:BCSF) issued its earnings results on Wednesday, August, 5th. The company reported $0.37 earnings per share for the quarter, hitting the Zacks' consensus estimate of $0.37. The company had revenue of $47.87 million for the quarter, compared to analysts' expectations of $54.71 million. Bain Capital Specialty Finance had a negative net margin of 20.85% and a positive return on equity of 8.61%.
View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, August 5th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.34 per share on Friday, October 30th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 12.92%. The ex-dividend date is Tuesday, September 29th.
View Bain Capital Specialty Finance's dividend history.

8 analysts have issued 12 month price targets for Bain Capital Specialty Finance's stock. Their forecasts range from $7.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's stock price to reach $12.14 in the next year. This suggests a possible upside of 15.3% from the stock's current price.
View analysts' price targets for Bain Capital Specialty Finance.

Some companies that are related to Bain Capital Specialty Finance include GS ACQUISITION /SH CL A (GSAH), Flying Eagle Acquisition (WPF), Flying Eagle Acquisition (FEAC), Jaws Acquisition (JWS), Artius Acquisition (AACQ), SOCIAL CAP HEDO/SH CL A (IPOB), Churchill Capital Corp II (CCX), DiamondPeak (DPHC), Leisure Acquisition (NEBU), Social Capital Hedosophia Holdings Corp. III (IPOC), FORTRESS VALUE /SH (FVAC), Federal Street Acquisition (FSAC), Conyers Park II Acquisition (CPAA), FORUM MERGER II/SH CL A (FMCI) and Gores Metropoulos (GMHI).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), Square (SQ), AT&T (T), Home Depot (HD), Advanced Micro Devices (AMD), Bank of America (BAC), Bristol-Myers Squibb (BMY) and CVS Health (CVS).

(BCSF) raised $156 million in an IPO on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bain Capital Credit LP (18.31%), UBS Group AG (3.31%), Bank of America Corp DE (2.05%), Starr International Co. Inc. (1.43%), Sumitomo Mitsui Trust Holdings Inc. (0.88%) and C.V. Starr & Co. Inc. Trust (0.74%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Parallel Advisors LLC, First Republic Investment Management Inc., Virtus ETF Advisers LLC, Two Sigma Advisers LP, Stephens Inc. AR, Mission Wealth Management LP, and Stifel Financial Corp.
View insider buying and selling activity for Bain Capital Specialty Finance.

BCSF stock was purchased by a variety of institutional investors in the last quarter, including Bain Capital Credit LP, UBS Group AG, Gillson Capital LP, Sumitomo Mitsui Trust Holdings Inc., PDT Partners LLC, Mckinley Capital Management LLC Delaware, Meridian Investment Counsel Inc., and WFA of San Diego LLC. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCSF stock can currently be purchased for approximately $10.53.

Bain Capital Specialty Finance has a market capitalization of $679.84 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]